Cannabinoid science is an ever-evolving and rapidly changing field as continued research is being done and daily discoveries are happening.
Below I have listed medical research journals, online publications, websites dedicated to cannabis education, and/or CBD in the news. Even though this list is not comprehensive I will continually be adding more and more resources. If there is a relevant publication I have missed, feel free to comment as I look forward to providing a complete resource guide.
Are you interested in participating in a CBD clinical study? This list provides nationwide recruitment for clinical trials.
- Some of the media articles display the author’s opinion about either cannabis, medical marijuana with or without THC, and/or CBD. Keep in mind, these opinions may differ from yours or mine and it does not necessarily reflect the opinion of Herb ‘N Oil.
- Since more and better research is needed, including larger clinical trials, more double-blind studies, and long-term effects, it is important to make note that some of this research has been animal testing and may be in different languages from other countries around the world.
- CBD is not (yet) FDA-approved. Herb ‘N Oil products are not intended to diagnose, treat, cure or prevent any diseases or disorders. Please consult a doctor before use.
Medical Journals and Publications
Alcoholism and Addiction
Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. | Ren Y1, Whittard J, Higuera-Matas A, Morris CV, Hurd YL.
Transdermal Delivery of Cannabidiol Attenuates Binge Alcohol-Induced Neurodegeneration in a Rodent Model of an Alcohol Use Disorder | Daniel J. Liput,aDana C. Hammell,bAudra L. Stinchcomb,b,c and Kimberly Nixona
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.| Gonzalez-Cuevas G1,2, Martin-Fardon R1, Kerr TM1, Stouffer DG1, Parsons LH1, Hammell DC3, Banks SL4, Stinchcomb AL3, Weiss F5.
Anxiety, Fear and Emotional Processing
The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD). | Pretzsch CM1, Voinescu B1, Mendez MA1, Wichers R1, Ajram L1, Ivin G2, Heasman M2, Williams S3, Murphy DG1, Daly E1, McAlonan GM1.
Bone health, fractures, and Osteoporosis
Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts | Natalya M Kogan,1 Eitan Melamed,1 Elad Wasserman,1 Bitya Raphael,1,2 Aviva Breuer,3 Kathryn S Stok,4 Rachel Sondergaard,4 Ana VVillarreal Escudero,4 Saja Baraghithy,1 Malka Attar-Namdar,1 Silvina Friedlander-Barenboim,5 Neashan Mathavan,6,7 Hanna Isaksson,6,7 Raphael Mechoulam,3 Ralph Muller, € 4 Alon Bajayo,1 Yankel Gabet,2 * and Itai Bab1 *
Diabetes, Obesity, Kidney and GI health
Cannabinoid‐1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells | Adi Drori, 1 Anna Permyakova, 1 Rivka Hadar, 1 Shiran Udi, 1 Alina Nemirovski, 1 and Joseph Tam 1
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome | Shaun A. Hussain,Correspondence information about the author Shaun A. HussainEmail the author Shaun A. Hussain, Raymond Zhou, Catherine Jacobson, Julius Weng, Emily Cheng, Johnson Lay, Phoebe Hung, Jason T. Lerner, Raman Sankar
Treatment of Seizures Associated with Lennox-Gastaut and Dravet Syndromes: A Focus on Cannabidiol Oral Solution | Dovena Lazaridis, PharmD, BCPS, Nathaniel Eraikhuemen, PharmD, Kia Williams, BS, and Judith Lovince
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? | Russo EB1.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. | Mecha M1, Feliú A, Iñigo PM, Mestre L, Carrillo-Salinas FJ, Guaza C.
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy. | Ward SJ1, McAllister SD, Kawamura R, Murase R, Neelakantan H, Walker EA.
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial. | Chagas MH1, Zuardi AW2, Tumas V3, Pena-Pereira MA3, Sobreira ET3, Bergamaschi MM2, dos Santos AC2, Teixeira AL4, Hallak JE2, Crippa JA2.